CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
All cash amounts presented in text are in million with currency specification, all amounts are in PLN million, except where otherwise stated.
for the year ended 31 December 2016
Note | Number of shares | Share capital | Share premium | Other reserves | Retained earnings* | Equity attributable to equity holders of the Parent | Non-controlling interests | Total equity | |
---|---|---|---|---|---|---|---|---|---|
Balance as at 1 January 2016 | 639,546,016 | 25.6 | 7,174.0 | (3.7) | 3,054.2 | 10,250.1 | - | 10,250.1 | |
Acquisition of Litenite | 37 | - | - | - | - | - | - | 98.3 | 98.3 |
Total comprehensive income | - | - | - | 8.2 | 1,041.3 | 1,049.5 | (20.3) | 1,029.2 | |
Hedge valuation reserve | 29 | - | - | - | 7.9 | - | 7.9 | - | 7.9 |
Actuarial gain | - | - | - | 0.3 | - | 0.3 | - | 0.3 | |
Net profit for the period | - | - | - | - | 1,041.3 | 1,041.3 | (20.3) | 1,021.0 | |
Balance as at 31 December 2016 | 639,546,016 | 25.6 | 7,174.0 | 4.5 | 4,095.5 | 11,299.6 | 78.0 | 11,377.6 |
for the year ended 31 December 2015
Number of shares | Share capital | Share premium | Other reserves | Retained earnings* | Equity attributable to equity holders of the Parent | Total equity | |
---|---|---|---|---|---|---|---|
Balance as at 1 January 2015 | 639,546,016 | 25.6 | 7,237.4 | (12.2) | 1,890.8 | 9,141.6 | 9,141.6 |
Restatement resulting from purchase price allocation of Metelem** | - | - | (63.4) | - | - | (63.4) | (63.4) |
Balance as at 1 January 2015 restated** | 639,546,016 | 25.6 | 7,174.0 | (12.2) | 1,890.8 | 9,078.2 | 9,078.2 |
Total comprehensive income | - | - | - | 8.5 | 1,163.4 | 1,171.9 | 1,171.9 |
Hedge valuation reserve | - | - | - | 5.5 | - | 5.5 | 5.5 |
Actuarial gain | - | - | - | 3.0 | - | 3.0 | 3.0 |
Net profit for the period | - | - | - | - | 1,163.4 | 1,163.4 | 1,163.4 |
Balance as at 31 December 2015 | 639,546,016 | 25.6 | 7,174.0 | (3.7) | 3,054.2 | 10,250.1 | 10,250.1 |
* the capital excluded from distribution amounts to PLN 8.5 as at 31 December 2016 and 2015. In accordance with the provisions of the Commercial Companies Code, joint-stock companies are required to transfer at least 8% of their annual net profits to reserve capital until its amount reaches one third of the amount of their share capital
** restatement resulting from final purchase price allocation of Metelem (see note 37 in consolidated financial statements for 2015). The amount also includes share issuance-related costs